HOOKIPA Pharma (HOOK) announced that enrollment is complete in the Phase 1b clinical trial evaluating HB-500 for the treatment of HIV, with 30 participants enrolled across five sites in the United ...
In Nigeria, PEPFAR remains a major contributor to the treatment of People Living with HIV, covering approximately 90 per cent of the country's treatment needsThe National Agency for the Control of ...
Results that may be inaccessible to you are currently showing.